Preexisting BTK or PLCG2 mutation is exceedingly rare and comprises a minor fraction of CLL, if any [allele frequency of 0.0002% in a report by Burger et al. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.